An evaluation of simultaneously administered free and intrinsic factor bound radioactive cyanocobalamin in the diagnosis of pernicious anaemia in the elderly
- 1 March 1979
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 32 (3) , 244-250
- https://doi.org/10.1136/jcp.32.3.244
Abstract
The definitive diagnosis of pernicious anaemia (PA) in the elderly is by no means always straightforward, particularly when inappropriate medication has been introduced before the institution of specific investigatory procedures. A detailed haematological study was carried out on 301 patients aged 60-95 with a serum B12 concentration at the laboratory's lower level of normal of 150 ng per litre (Euglena gracilis assay). The diagnosis of PA was based on strict predetermined haematological criteria. All patients were subsequently studied by the simultaneous oral administration of the dual isotopes 57Co-labelled B12 bound to intrinsic factor and free 58Co-labelled B12 (Dicopac test), and urine was collected over 24 hours after an intramuscular dose of 1 mg nonradioactive B12 for estimation of the 57Co/58Co B12 ratio; 255 patients satisfied all criteria for final analysis. The Radiochemical Centre, Amersham suggests an upper limit of the normal range for the 57Co/58Co ratio of 1·3 with a lower limit for PA of 2·0. We were unable to show a sharp borderline in the 57Co/58Co B12 ratio between those patients shown by other criteria to have PA and those who do not have PA; 34% of the 71 established patients had a ratio below 2·0. From our series a ratio borderline drawn at 1·4 gave only one false negative (1·4% of the PA group). Of the 175 non-PA cases, nine (5%) gave false positive results; four of these had 58Co excretion levels high enough to make misdiagnosis unlikely. In a proportion of patients the 57Co/58Co B12 ratio was estimated at regular intervals for 36-hour periods. Maximum accuracy of isotope measurement on a single specimen was obtained 8-20 hours after isotope dosing. The Dicopac investigation is a useful simple screening test in the differential diagnosis of patients with a megaloblastic bone marrow and combined low serum B12 and folate concentrations. When carried out by the standard technique, the degree of discrimination between normal and abnormal ratios is of limited diagnostic significance in one-third of patients.Keywords
This publication has 17 references indexed in Scilit:
- Vitamin B12 Absorption Evaluated by a Dual Isotope Test (Dicopac®) Results of Radioactivity Measurements in Plasma and in UrineScandinavian Journal of Haematology, 1974
- Expected and observed values for the prescription of vitamin B 12 in England and Wales.Journal of Epidemiology and Community Health, 1971
- Deranged DNA Synthesis by Bone Marrow from Vitamin B12‐Deficient Humans*British Journal of Haematology, 1968
- Anaemia in Geriatric PatientsGerontologia Clinica, 1968
- Simultaneous free and bound radioactive vitamin B12urinary excretion testJournal of Clinical Pathology, 1965
- THE FUNCTION OF VITAMIN B12 AND FOLIC ACID COENZYMES IN MAMMALIAN CELLS*Medicine, 1964
- Studies on the folic acid activity of human serumJournal of Clinical Pathology, 1961
- Results of Three Years' Experience with Microbiological Assay of Vitamin B12 in SerumBMJ, 1958
- Absorption of Radioactive Vitamin B12 after Total GastrectomyNew England Journal of Medicine, 1954
- Vitamin B12Assay in Body Fluids usingEuglena gracilisJournal of Clinical Pathology, 1952